-
Start Preamble
ACTION:
Notice of registration.
SUMMARY:
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of schedule I and II controlled substances.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as bulk manufacturers of schedule I or schedule II controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.
Company FR docket Published Johnson Matthey, Inc 84 FR 5477 February 21, 2019. Stepan Company 84 FR 5499 February 21, 2019. Research Triangle Institute 84 FR 5501 February 21, 2019. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of the registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.
Start SignatureDated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10026 Filed 5-14-19; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 05/15/2019
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of registration.
- Document Number:
- 2019-10026
- Pages:
- 21814-21814 (1 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2019-10026.pdf